about
Leukocyte mimetic polysaccharide microparticles tracked in vivo on activated endothelium and in abdominal aortic aneurysm.Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats.Autologous mesenchymal stem cell endografting in experimental cerebrovascular aneurysms.Low levels of low-density lipoprotein-C associated with proprotein convertase subtilisin kexin 9 inhibition do not increase the risk of hemorrhagic transformation.Epo deficiency alters cardiac adaptation to chronic hypoxia.Inhibition of ERK1/2 phosphorylation: a new strategy to stimulate elastogenesis in the aorta.Fucoidan interferes with Porphyromonas gingivalis-induced aneurysm enlargement by decreasing neutrophil activation.Acceleration of tendon healing using US guided intratendinous injection of bevacizumab: first pre-clinical study on a murine model.In vitro and in vivo hemocompatibility evaluation of a new dermatan sulfate-modified PET patch for vascular repair surgery.Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model.USPIO size control through microwave nonaqueous sol-gel method for neoangiogenesis T2 MRI contrast agent.Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.Efficacy of intra-tendinous injection of platelet-rich plasma in treating tendinosis: comprehensive assessment of a rat modelBimodal Fucoidan-Coated Zinc Oxide/Iron Oxide-Based Nanoparticles for the Imaging of Atherothrombosis
P50
Q30809776-0D1C9830-ABD1-455E-9F9F-814A0FF5EA8FQ33886784-C15E0609-0E4E-43A2-9548-F2B57BD90D4DQ34628938-ED16916A-6398-42BB-8FD2-A3BC15F10C74Q38966066-A43D295F-1C8B-484B-BC9B-060043801BDFQ43929563-56A9FE8B-6575-40EF-936A-EF7002B0B4CBQ44071279-57C0F623-9C42-477E-A959-5E9EC6093ACEQ44376660-34145D08-B687-4D11-AE07-AD45BCB94C03Q44660385-583FE5DF-B685-4BE0-BEB0-2FD791375EDEQ46523895-A712A37F-4E47-4437-BBB7-24FC486D39E4Q46954680-DB72B5E8-18F5-405E-B8FF-E1E1FD225A99Q47267713-54E09C74-8079-44B6-BE0F-570F926AC87DQ51546341-F2209F63-D79F-483E-8553-4B8DA8AB622EQ52676402-45FAFA19-355C-4530-A7EE-030D2CE24BC0Q56839370-EB538DBA-00E4-4238-BD03-88B8C0130430Q64116786-AC4EB6A4-323E-49DD-882F-FD9ACA9AB50C
P50
description
researcher ORCID ID = 0000-0003-4467-435X
@en
wetenschapper
@nl
name
Clément Journé
@ast
Clément Journé
@en
Clément Journé
@nl
type
label
Clément Journé
@ast
Clément Journé
@en
Clément Journé
@nl
prefLabel
Clément Journé
@ast
Clément Journé
@en
Clément Journé
@nl
P106
P31
P496
0000-0003-4467-435X